Compensation for Uloric Gout Medication Users who Suffered Heart Attack, Stroke, Unstable Angina, Death

Uloric is a newer generation gout medication that recently received a boxed warning from the FDA due to an increased risk of heart-related death. It is also linked to other adverse cardiovascular events such as heart attack, stroke, unstable angina. At the same time, a safer, more reliable medicine had long been available for a fraction of the price.

In 2019, the FDA determined it will require a boxed warning to be placed on all prescriptions of Uloric. The boxed warning, also known as the “black box warning” is the most severe warning the FDA can assign. It is only used when there is reasonable evidence that a medication is likely to cause serious or life-threatening side effects, in this case, serious cardiovascular events such as heart attack or myocardial infarction, stroke, unstable angina or cardiovascular death.

Symptoms Associated with Uloric Related Cardiovascular Injuries

There has been an increase in heart-related events such as cardiovascular death, heart attack and stroke for those taking Uloric.

Uloric should not be stopped abruptly. Talk to your health care professional if you are considering stopping the medication.

Seek emergency medical attention immediately if any of the following side effects occur while taking Uloric:

  • Chest pain
  • Shortness of breath
  • Rapid or irregular heartbeat
  • Numbness or weakness on one side of your body
  • Dizziness
  • Trouble talking
  • Sudden severe headache

Whistleblower Uloric Lawsuit

"The Drug Safety Communication released by the FDA stated there was an increased risk of death with the use of Uloric compared to Zyloprim (allopurinol). A black box warning for cardiovascular death and usage limited to only patients with symptomatic hyperuricemia."

A former safety consultant for Uloric manufacturer, Takeda Pharmaceuticals, issued a whistleblower lawsuit where he claimed the company knew about the risks associated with Uloric, yet failed to inform the public. The risks the company allegedly knew about include liver issues, kidney damage, and bone marrow failure.

Also included in the complaint was the allegation that Takeda knew that Uloric could be fatal when combined with select prescription drugs. It went even further to accuse the company of taking steps to conceal the dangers from the public. The lawsuit was eventually dismissed, but it raises bigger ethical questions surrounding Uloric and its manufacturer, Takeda.

Rate This Service

4.6/5 - (61 votes)

Did you or a loved one suffer Heart Attack, Stroke, Unstable Angina or Death while taking Gout Medication Uloric?

Find out if you qualify for compensation.

Find Out More
Copyright © 2016-2017 Consumer Safety Watch. All Rights Reserved. Privacy / Terms / Disclaimer

Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.